Tectonic Therapeutic (TECX) Share-based Compensation (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Share-based Compensation of $3.7 million for Q1 2026, up 77.37% year-over-year from $2.1 million in Q1 2025, and up 24.79% quarter-over-quarter from $3.0 million in Q4 2025.
Tectonic Therapeutic (TECX) Share-based Compensation (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Share-based Compensation for 10 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 77.37% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $11.6 million (up 433.41% YoY), while the FY2025 annual figure was $10.5 million, down 21.08% from the prior year.
- Share-based Compensation improved to $3.7 million in Q1 2026 per TECX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $24.0 million in Q2 2025 and bottomed at -$2.0 million in Q4 2024.
- Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2023 — Share-based Compensation soared 252900.0% — and 2024, when it sank 771.43%.
- Tectonic Therapeutic's Share-based Compensation stood at $2000.0 in 2022, then soared by 14600.0% to $294000.0 in 2023, then slumped by 771.43% to -$2.0 million in 2024, then surged by 251.42% to $3.0 million in 2025, then gained by 24.79% to $3.7 million in 2026.
- Business Quant data shows TECX's Share-based Compensation at $3.7 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.49 Mn |
| Jun 30, 2026 | 3.49 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 403,000.00 |
| Jun 30, 2024 | 403,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Mar 31, 2024 | 321,000.00 |